Literature DB >> 19918611

Quantification of acetaldehyde and carbon dioxide in the headspace of malignant and non-malignant lung cells in vitro by SIFT-MS.

Josep Sulé-Suso1, Andriy Pysanenko, Patrik Spanel, David Smith.   

Abstract

Previous studies using selected ion flow tube mass spectrometry, SIFT-MS, showed that CALU-1 lung cancer cell cultures emit acetaldehyde in proportion to the number of cells in the culture medium. However, studies in another laboratory led to conflicting results, so these SIFT-MS studies have been repeated and extended to include NL20 normal lung epithelial cells and 35FL121 Tel+ telomerase positive lung fibroblast cells. Thus, SIFT-MS has been used to quantify acetaldehyde and, additionally, carbon dioxide, acetone and ethanol in the headspace of the cell culture medium alone and the headspace of the appropriate medium containing 50 x 10(6) or 80 x 10(6) cells following incubation for 16 h at 37 degrees C. Three independent experiments were carried out for each cell type for both cell numbers and for each of the two culture media used. The results showed that acetone and ethanol were only released by the culture medium, specifically from the foetal calf serum contained in the medium, and not by the cells. Acetaldehyde was also released by the medium, but at relatively lower levels than the other three compounds, and was also generated by the CALU-1 and NL20 cell cultures in proportions to the number of cells in the medium. However, following incubation, the acetaldehyde levels in the headspace of the 35FL121 Tel+ cell cultures were much lower than those present in the headspace of the medium alone. Carbon dioxide was clearly generated by the CALU-1 and 35FL121 Tel+ cells indicating that they were respiring normally, but much less was produced by the NL20 cells, presumably indicating that normal metabolism was being inhibited.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19918611     DOI: 10.1039/b916158a

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  8 in total

Review 1.  The clinical potential of exhaled breath analysis for diabetes mellitus.

Authors:  Timothy Do Chau Minh; Donald Ray Blake; Pietro Renato Galassetti
Journal:  Diabetes Res Clin Pract       Date:  2012-03-10       Impact factor: 5.602

2.  Product ion distributions for the reactions of NO+ with some physiologically significant aldehydes obtained using a SRI-TOF-MS instrument.

Authors:  Paweł Mochalski; Karl Unterkofler; Patrik Španěl; David Smith; Anton Amann
Journal:  Int J Mass Spectrom       Date:  2014-04-15       Impact factor: 1.986

Review 3.  Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer.

Authors:  Kamila Schmidt; Ian Podmore
Journal:  J Biomark       Date:  2015-03-30

Review 4.  A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines.

Authors:  Wojciech Filipiak; Pawel Mochalski; Anna Filipiak; Clemens Ager; Raquel Cumeras; Cristina E Davis; Agapios Agapiou; Karl Unterkofler; Jakob Troppmair
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 5.  Assessment, origin, and implementation of breath volatile cancer markers.

Authors:  Hossam Haick; Yoav Y Broza; Pawel Mochalski; Vera Ruzsanyi; Anton Amann
Journal:  Chem Soc Rev       Date:  2013-12-04       Impact factor: 54.564

6.  Unique volatolomic signatures of TP53 and KRAS in lung cells.

Authors:  M P A Davies; O Barash; R Jeries; N Peled; M Ilouze; R Hyde; M W Marcus; J K Field; H Haick
Journal:  Br J Cancer       Date:  2014-07-22       Impact factor: 7.640

Review 7.  Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?

Authors:  Sabrina Lagniau; Kevin Lamote; Jan P van Meerbeeck; Karim Y Vermaelen
Journal:  Oncotarget       Date:  2017-05-17

8.  Volatile fingerprinting of human respiratory viruses from cell culture.

Authors:  Giorgia Purcaro; Christiaan A Rees; Wendy F Wieland-Alter; Mark J Schneider; Xi Wang; Pierre-Hugues Stefanuto; Peter F Wright; Richard I Enelow; Jane E Hill
Journal:  J Breath Res       Date:  2018-03-01       Impact factor: 3.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.